The Beneficial Effects of Bisphosphonate-enoxacin on Cortical Bone Mass and Strength in Ovariectomized Rats-Reference-Cited by-同舟云学术

The Beneficial Effects of Bisphosphonate-enoxacin on Cortical Bone Mass and Strength in Ovariectomized Rats

Published:2017-06-07 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Liu Xuqiang,Qu Xinhua,Nie Tao,Zhai Zanjing,Li Haowei,Ouyang Zhengxiao,Qin An,Zhang Shuhong,Zhang Shuangyan,Fan Qiming,Tang Tingting,Yu Zhifeng,Dai Min

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference35 articles.

1. Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.;Amugongo;Bone,2014

2. Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.;Bala;J. Bone Miner. Res.,2014

3. Modifications of bone material properties in postmenopausal osteoporotic women long-term treated with alendronate.;Bala;Eur. J. Endocrinol.,2011

4. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women.;Boivin;Bone,2000

5. Bone histomorphometry of transiliac paired bone biopsies after 6 or 12 months of treatment with oral strontium ranelate in 387 osteoporotic women: randomized comparison to alendronate.;Chavassieux;J. Bone Miner. Res.,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zoledronate reduces loading-induced microdamage in cortical ulna of ovariectomized rats;Journal of the Mechanical Behavior of Biomedical Materials;2024-02

2. Zoledronate reduces loading-induced microdamage in cortical ulna of ovariectomized rats;2023-05-14

3. The dark side of foetal bovine serum in extracellular vesicle studies;Journal of Extracellular Vesicles;2022-10

4. Management of Osteoporosis in Men: A Narrative Review;International Journal of Molecular Sciences;2021-12-20

5. Bisphosphonate‐enoxacin inhibit osteoclast formation and function by abrogating RANKL‐induced JNK signalling pathways during osteoporosis treatment;Journal of Cellular and Molecular Medicine;2021-10-15